Caricamento...
Melanoma brain metastases: review of histopathological features and immune-molecular aspects
Patients with melanoma brain metastases (MBM) have a dismal prognosis, but the unprecedented advances in systemic therapy alone or in combination with local therapy have now extended the 1-year overall survival rate from 20–25% to nearing 80–85%, mainly in asymptomatic patients. The histopathologica...
Salvato in:
| Pubblicato in: | Melanoma Manag |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Future Medicine Ltd
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7426753/ https://ncbi.nlm.nih.gov/pubmed/32821376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2019-0021 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|